|
POU5F1 (OCT4): The Core Transcription Factor Governing Pluripotency, Development, and Disease
hits:35 Date:05/06/26
POU5F1 (OCT4): The Core Transcription Factor Governing Pluripotency, Development, and Disease—Powered by ANT BIO PTE. LTD.
1. Concept
POU5F1 (also known as OCT4) is a pivotal transcription factor belonging to the POU family, encoded by a gene located on human chromosome 6p21.31. It is indispensable for maintaining embryonic stem cell pluripotency and mediating cellular reprogramming.
Structurally, POU5F1 consists of 360 amino acids, with a conserved POU domain (residues 134–286) that forms a helix-turn-helix structure. This domain comprises two independent DNA-binding subunits (POU-specific and POU homeodomain) linked by a flexible peptide, enabling "bipartite" DNA recognition—binding the 5'-ATGCAAAT-3' core sequence via the POU-specific domain and flanking sequences via the POU homeodomain. Alternative splicing generates isoforms like OCT4A (nuclear-localized, main pluripotency mediator) and OCT4B (cytoplasmic, involved in stress responses). POU5F1 forms regulatory networks with SOX2 and NANOG, activating pluripotency genes and repressing differentiation-related genes to control cell fate.
2. Research Frontiers
POU5F1 research is advancing across regenerative medicine, oncology, and developmental biology. A key frontier is optimizing its role in induced pluripotent stem cell (iPSC) reprogramming—developing small molecules (e.g., vitamin C, valproic acid) to modulate POU5F1 expression, and transient mRNA/protein delivery to avoid genomic integration. In cancer therapy, strategies targeting POU5F1 (antisense oligonucleotides, siRNAs, miR-145 mimics) are being tested to suppress cancer stem cell properties.
Single-cell technologies reveal POU5F1 expression heterogeneity in stem cell populations and dynamic "transcriptional condensates" in nuclei, reshaping understanding of pluripotency regulation. CRISPR/dCas9-based epigenetic editing enables precise control of the POU5F1 locus, offering therapeutic potential. Future directions include exploring species-specific regulatory differences, developing cell-type-specific delivery systems, and integrating POU5F1 into preimplantation genetic screening (PGS) for assisted reproduction.
3. Research Significance
POU5F1’s significance lies in its central role as a pluripotency master regulator. It revolutionized regenerative medicine through iPSC technology, enabling disease modeling, drug screening, and cell therapy development. In oncology, it serves as a marker for cancer stem cells and a potential therapeutic target, addressing therapy resistance and metastasis.
In developmental biology, it clarifies early embryonic cell fate determination, while in reproductive medicine, it improves oocyte quality assessment and IVF success rates. Basic research on POU5F1 deepens understanding of epigenetic regulation and cell fate transitions, while translational efforts advance precision medicine across multiple fields.
4. Biological Roles, Clinical Implications, and Product Support
4.1 Core Biological Functions
4.1.1 Early Embryonic Development
• POU5F1 is maternally derived in oocytes, activating the zygotic genome post-fertilization.
• High expression is maintained through the morula stage, then restricted to the inner cell mass (ICM) of blastocysts; downregulated in trophectoderm.
• Gene knockout leads to failed ICM development and early embryonic lethality, confirming its essential role in pluripotency maintenance.
4.1.2 Cellular Reprogramming
• A key factor in iPSC generation (with SOX2, KLF4, c-MYC), initiating pluripotency gene expression (NANOG, REX1) and suppressing differentiation.
• Epigenetic functions: Recruits chromatin remodelers and demethylases to open closed chromatin, facilitating transcription factor binding.
4.1.3 Germ Cell Development
• High expression in primordial germ cells (PGCs) preserves undifferentiated states; downregulated during meiosis.
• Aberrant expression in male germ cells correlates with seminoma development; serves as a marker for oocyte quality in assisted reproduction.
4.1.4 Cancer Biology
• Dysregulated expression in seminomas, bladder, breast, and liver cancers, promoting cancer stem cell properties, EMT, and chemotherapy resistance.
• Dose-dependent effects: Moderate expression drives tumorigenesis; overexpression induces senescence/apoptosis.
4.2 Clinical Applications and Therapeutic Strategies
• Regenerative Medicine: Optimized iPSC generation for disease modeling and cell therapies, using POU5F1 modulators to improve efficiency and safety.
• Oncology: Targeted inhibition of POU5F1 to suppress cancer stem cells; serves as a prognostic marker for tumor grade and metastasis.
• Reproductive Medicine: POU5F1 expression analysis integrated into PGS to assess embryonic developmental potential.
4.3 How ANT BIO PTE. LTD. Products Support POU5F1 Research
ANT BIO PTE. LTD., through its sub-brand Starter (specializing in antibodies), provides high-quality POU5F1-specific antibodies for research and validation.
Key products and applications:
• S0B2126 (OCT3/4 Recombinant Rabbit mAb): Targets POU5F1 (OCT4), ideal for detecting expression in stem cells, embryos, and tumor samples via Western blotting, immunofluorescence, and immunohistochemistry.
• S0B2126P (OCT3/4 Recombinant Rabbit mAb, PBS Only): PBS-formulated antibody for applications requiring minimal buffer interference, such as flow cytometry and immunoprecipitation.
Both antibodies offer high specificity and affinity, ensuring reliable detection of POU5F1 isoforms and expression patterns—critical for pluripotency validation, reprogramming efficiency assessment, and cancer research.
5. Brand Mission
ANT BIO PTE. LTD. is dedicated to empowering the global life science community with high-quality, innovative biological reagents and solutions. With 15 years of antibody development experience, the company leverages advanced platforms—including recombinant antibody development (rabbit/mouse monoclonal), recombinant protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—to deliver a comprehensive product portfolio.
Through its three specialized sub-brands—Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins)—ANT BIO PTE. LTD. adheres to international certifications (EU 98/79/EC, ISO9001, ISO13485) and strict quality standards. The company’s mission is to accelerate scientific discovery by providing tools that enhance experimental precision, efficiency, and reproducibility. ANT BIO PTE. LTD. is committed to supporting POU5F1 research and global efforts in regenerative medicine, oncology, and reproductive biology, ultimately advancing human health through interdisciplinary collaboration and innovation.
6. Related Product List
| Product Code |
Product Name |
Product Details |
| S0B2126 |
OCT3/4 Recombinant Rabbit mAb (SDT-165-76) |
Host: Rabbit |
| S0B2126P |
OCT3/4 Recombinant Rabbit mAb, PBS Only (SDT-165-76) |
Host: Rabbit |
7. AI Disclaimer
This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
|
中文
